PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanolic extract of B. nigra seeds showed a concentration-dependent growth-inhibitory effect and induced apoptosis in A549 and H1299 human non-small cell lung cancer cell lines [PMID:32365503].
B. nigra essential oil inhibited the growth of Aspergillus ochraceus, Penicillium citrinum, and Aspergillus niger via direct contact and vapor phase exposure [PMID:25836415].
Extracts demonstrated antibacterial activity against Staphylococcus epidermidis [PMID:42196580].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27043505 (2016) — Sinigrin and Its Therapeutic Benefits. · Molecules (Basel, Switzerland)
- 2.PMID: 29521240 (2019) — Brassica Nigra: Ethopharmacological Review of a Routinely Used Condiment. · Current drug discovery technologies
- 3.PMID: 34574199 (2021) — Biologically Active Compounds in Mustard Seeds: A Toxicological Perspective. · Foods (Basel, Switzerland)
- 4.PMID: 33666283 (2021) — Phytotherapy and food applications from Brassica genus. · Phytotherapy research : PTR
- 5.PMID: 29361740 (2018) — Brassicaceae Mustards: Traditional and Agronomic Uses in Australia and New Zealand. · Molecules (Basel, Switzerland)